Literature DB >> 24960501

Simultaneous laparoscopy-assisted resection for rectal and gastric cancer.

Hongbo Wei1, Jiafeng Fang Master2, Tufeng Chen2, Zongheng Zheng2, Bo Wei2, Yong Huang2, Jianglong Huang2, Haozhong Xu Master2.   

Abstract

Laparoscopy-assisted surgery for either rectal or gastric cancer has been increasingly performed. However, simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer is rarely reported in the literature. In our study, 3 cases of patients who received simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer were recorded. The results showed that all 3 patients recovered well, with only 253 minutes of mean operation time, 57 mL of intraoperative blood loss, 5 cm of assisted operation incision, 4 days to resume oral intake, 12 days' postoperative hospital stay, and no complication or mortality. No recurrence or metastasis was found within the follow-up period of 22 months. When performed by surgeons with plentiful experience in laparoscopic technology, simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer is safe and feasible, with the benefits of minimal trauma, fast recovery, and better cosmetic results, compared with open surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24960501      PMCID: PMC4035648          DOI: 10.4293/108680813X13753907291350

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

The occurrence of synchronous cancer is a life-threatening condition and remains an issue of great interest and challenge to surgeons. Although the coexistence of synchronous gastric and rectal cancer is rare, it has been reported that the frequency of synchronous rectal and gastric cancer ranges between 1.3% and 3.9%.[1,2] Surgical resection is unequivocally essential for synchronous rectal and gastric cancer. A wide incision is required for conventional open surgery in case of these diseases, which results in a poor cosmetic outcome and an impaired quality of postoperative life. In addition, long surgical time and severe trauma may result in postoperative complications and a delayed recovery. Laparoscopy-assisted resection for either rectal or gastric cancer is performed worldwide, and its advantages over conventional open surgery have been demonstrated.[3-5] However, simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer is rarely reported. In the present study, we present 3 cases of synchronous rectal and gastric cancer, which were resected at the same laparoscopic surgery, and we discuss its feasibility and advantages.

CASE REPORTS

Clinical Data

Case 1.

A 78-year-old woman was admitted to our hospital in March 2010 with complaints of altering bowel habits for 1-month duration. Her past medical history included hypertension, type 2 diabetes mellitus, multiple cerebral infarction, and lung infection. Digital rectal examination revealed a palpable, tough, and mobile mass 6 cm from the anal verge. Serum CA19-9 level was 76 U/mL, and the Carcinoembryonie Antigen (CEA) level was normal. Colonoscopy demonstrated a circumferential mass 5 cm away from the anal verge, and biopsy findings showed a moderately differentiated rectal adenocarcinoma (. Computed tomography scan of the abdomen revealed rectal cancer invading the serosa layer with enlargement of surrounding lymph nodes, and an unexpected duodenal diverticulum (. To confirm the character of the duodenal diverticulum, gastroscopy was performed, which showed no abnormalities in the duodenum but revealed an ulcerative lesion located in the body of the stomach, and biopsy confirmed the gastric lesion to be poorly differentiated gastric adenocarcinoma (. Furthermore, endoscopic ultrasonography indicated that the tumor in the stomach had invaded the serosa layer, with no obvious lymph node enlargement. A chest radiograph and radionuclide bone scan were performed to exclude distal metastasis. The preoperative staging of gastric cancer was T3N0M0, stage IIA, and of rectal cancer it was T4N0∼1M0, stage IIB∼IIIB (. Rectal cancer diagnosed by colonoscopy and biopsy. Rectal cancer and duodenal diverticulum presented by computed tomography scan. Gastric cancer diagnosed by gastroscopy and biopsy. Preoperative Clinical Data of the 3 Patients BMI, body mass index.

Case 2.

A 75-year-old female patient was admitted to our hospital in April 2010 because of intermittent left lower abdominal pain for 1 year, which had been aggravated for 2 weeks. Her past medical history was positive for hypertension, hyperlipidemia, and cerebral infarction. No abnormality was detected on her physical examination. Colonoscopy revealed a circumferential mass 12 cm from the anal verge, and biopsy results showed moderately differentiated rectal adenocarcinoma. A computed tomography scan of the abdomen demonstrated rectal cancer as well as thickening of the gastric antrum, with no lymph node enlargement around the rectum or stomach. Gastroscopy was performed to identify the lesion of the gastric antrum, and the biopsy results showed moderately to poorly differentiated gastric adenocarcinoma. Chest radiography and a radionuclide bone scan were performed to exclude distal metastasis of either rectal or gastric cancer. The preoperative staging of gastric cancer was T3N0M0, stage IIA, and of rectal cancer was T3N0M0, stage IIA.

Case 3.

A 55-year-old female patient was admitted to our hospital in December 2012 because of upper abdominal pain with bloody stool for 6 months. No abnormality was detected on physical examination. Colonoscopy revealed a circumferential mass 11 cm from the anal verge, and biopsy results showed moderately differentiated rectal adenocarcinoma. Gastroscopy revealed a lesion of the gastric antrum, and the biopsy results showed moderately to poorly differentiated gastric adenocarcinoma. Computed tomography scan of the abdomen demonstrated rectal cancer invading the serosa layer, with lymph node enlargement around the rectum, as well as gastric cancer invading the mucous layer, with no lymph node enlargement around the stomach. Chest radiography and a radionuclide bone scan were performed to exclude distal metastasis of either rectal or gastric cancer. The preoperative staging of gastric cancer was T1-2N0M0, stage IA–IB, and of rectal cancer was T4N0-1M0, stage IIB–IIIB.

Preoperative Preparations

All 3 patients were diagnosed as having synchronous rectal and distal gastric cancer. Various treatment strategies were discussed, and simultaneous laparoscopy-assisted low anterior resection for rectal cancer and laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy were chosen. Sufficient preoperative evaluations were performed because of age and complicated past medical history in all patients. Relevant diagnostic examinations including Holter monitoring, echocardiography, pulmonary function tests, and brain magnetic resonance imaging scans were performed, and subspecialties including anesthesia, surgical intensive care unit, cardiology, endocrinology, and neurology were consulted. Informed consent was given for simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer.

Surgical Procedures

Details of the surgical procedures for the 3 patients were similar. The operations were performed under general anesthesia. A Veress needle was used to establish a pneumoperitoneum, and the intra-abdominal pressure was maintained at a level of 15 mm Hg. A 10-mm trocar was placed just below the umbilicus for a 30-degree videoscope, and another 3 trocars were placed for manipulation at McBurney point, left and right lateral side of the rectus abdominis at the level of umbilicus, respectively. The patients were first placed in the lithotomy position to finish the low anterior resection. The sigmoid mesocolon and mesorectum were dissected along the inner side of the ureter by harmonic scalpel. The vessels and lymphatics were ligated at the root of the inferior mesenteric vessel with polymer clips (, whereas the distal rectum was transected intracorporeally with a 60-mm laparoscopic linear stapler (. After that, the first part of the operation was completed. Ligation of the inferior mesenteric vessel. Transection of the distal rectum intracorporeally. Then the patients were placed in the Trendelenburg position and another trocar was placed at the crossing point of the left costal margin and the anterior axillary line to complete the lymph node dissection and distal gastrectomy. First, the greater omentum, together with the frontal layer of the transverse mesocolon and the pancreatic capsule, were dissected from the splenic flexure to the hepatic flexure (. The right gastroepiploic vessels were ligated and the No. 6 lymph nodes were dissected simultaneously. Then the hepatoduodenal ligament and the No. 12 lymph nodes were dissected. Afterward, the right gastric artery, common hepatic artery, and left gastric artery were ligated gradually, together with the dissection of the No. 5, No. 8, and No. 7 lymph nodes, respectively (. After the dissection of the No. 1 lymph nodes, the stomach was totally mobilized with an adequate perigastric lymphadenectomy. The distal stomach and the first portion of the duodenum were also transected intracorporeally with a 60-mm laparoscopic linear stapler (. After that, the second part of the operation was completed. Dissection of the greater omentum. Lymph node dissection of gastric cancer. Transection of the distal stomach and the first portion of the duodenum intracorporeally. The final part of the operation was to finish the digestive reconstruction and complete the sigmoidorectostomy. A 5-cm median epigastric incision was made to remove the proximal rectum, the distal stomach, and the surrounding tissues of the rectum and stomach. A Billroth II reconstruction with a 25-mm intraluminal stapler was completed extracorporeally for gastric cancer. Correspondingly, the sigmoidorectostomy was completed with a 29-mm intraluminal stapler intracorporeally (. Finally, two drainage tubes were placed below the liver and in the pelvic cavity, respectively. Anastomosis of rectal cancer intracorporeally.

RESULTS

The surgical procedures of 3 patients were performed without any intraoperative complication. Mean operation time was 253 minutes, and intraoperative blood loss was 57 mL. The patients recovered well and resumed an oral diet in 4 days. The average postoperative hospital stay was 12 days. Meanwhile, postoperatively complication or mortality did not occur (. A 5-cm assisted incision led to a better cosmetic result and improved postoperative quality of life for patients (. Perioperative and Postoperative Data of the 3 Patients LALAR = laparoscopy-assisted low anterior resection; LADG = laparoscopy-assisted distal gastrectomy. A short operation incision and good cosmetic results of the surgery. The pathologic examination of case 1 showed moderately to poorly differentiated gastric adenocarcinoma invading the serosa layer with no lymph node metastasis and poorly differentiated rectal adenocarcinoma invading the muscular layer, with no lymph node metastasis. In contrast, the pathologic result of case 2 showed moderately to poorly differentiated gastric adenocarcinoma invading the serosa layer, with 2 of the 20 lymph nodes' metastasis and moderately differentiated rectal adenocarcinoma invading the muscular layer with no lymph node metastasis. In addition, the pathologic result of case 3 showed moderately to poorly differentiated gastric adenocarcinoma invading the submucosa layer with no lymph node metastasis and moderately differentiated rectal adenocarcinoma invading the serosa layer with 1 of the 24 lymph node metastases (. Gross specimens and microscopic results of gastric cancer and rectal cancer (Case 1). On the basis of their pathologic reports, all 3 patients were recommended for adjuvant chemotherapy, but only the last patient (case 3) accepted a XELOX regimen of adjuvant chemotherapy, and the other two patients declined chemotherapy because of their fear of the side effects of chemotherapeutic agents. However, all 3 cases complied with regular follow-up and, fortunately, postoperative surveillance, including serum tumor markers, chest radiographs, abdomen computed tomography scan, and endoscopy, revealed no recurrence or metastasis in all patients (. Oncologic Outcomes of the 3 Patients

DISCUSSION

The incidence of multiple primary cancers (MPC), especially synchronous MPC, is rare, ranging between 0.5% and 3% in China, which is much lower than that in other countries and may be related to the difference in diagnostic level.[6] In our study, the first two patients were admitted to the hospital for rectal cancer, but they did not present with specific symptoms of gastric cancer, which was diagnosed incidentally by computed tomography scan of the abdomen for exclusion of abdominal metastasis of “primary tumorrectal cancer. Therefore, complete laboratory examinations and imaging studies such as computed tomography scan of the abdomen, endoscopy, and tumor markers should be arranged to prevent other tumors from being missed. Thus, it emphasizes the importance of a thorough investigation and exploration before carrying out elective surgery. As a main treatment for digestive synchronous MPC, simultaneous surgical resection indicates more difficulties and higher operation risk than surgical resection for single tumor. Today, laparoscopy-assisted surgery has been performed worldwide and laparoscopy-assisted colorectal surgery has even been advocated as the standard treatment for colorectal cancer because of less trauma and faster recovery, with similar oncologic outcome.[7,8] However, simultaneous laparoscopy-assisted resection for digestive synchronous MPC is rarely reported in the literature. One case report of esophageal cancer with a sigmoid colon tumor treated by laparoscopic surgery and another case of a laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors indicated that laparoscopy-assisted resection for digestive synchronous MPC is feasible and safe.[9,10] Ten cases of simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancers have been reported by 3 surgeons, and the results showed a fast recovery, low incidence of complication, and a good cosmetic result.[11-13] In the present study, various treatment strategies were discussed for these 3 patients and finally surgical resection was arranged, although the operation was challenging because of the advanced ages and multiple medical diseases of these patients. A conventional open resection for synchronous rectal and gastric cancer required a wide incision from the xiphoid to the pubic symphysis, which may lead to a poor cosmetic result and impaired quality of postoperative life. Meanwhile, a long operation time and severe trauma may result in postoperative complications and a delayed recovery. Our surgeons have performed numerous laparoscopy-assisted surgeries and are experienced in laparoscopic technology, so we performed simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancer. Instead of a wide incision, we made several small incisions for trocar placement and a 5-cm assisted incision, which led to a better cosmetic result and improved quality of postoperative life. Meanwhile, patients had less postoperative pain and analgesic use, early mobility, quick recovery of gastrointestinal function, and fewer postoperative complications such as pneumonia, bed sores, and thromboembolism. In addition, advanced laparoscopic instruments containing harmonic scalpel, titanium, and polymer clips ensured a better hemostatic effect and reduced intraoperative bleeding. All patients regained mobility on the second postoperative day, resumed oral intake on the third to fifth postoperative day, and were discharged on the 10th to 14th postoperative day. The results were similar to those of single laparoscopy-assisted gastrectomy and even better than those of single open gastrectomy,[14,15] which supported the feasibility and advantages of this operation. Furthermore, at least 16 lymph nodes were dissected for both rectal and gastric cancers, and no recurrence or metastasis was found within a mean follow-up of 22 months, which suggested a similar oncologic outcome compared with open surgery. In the present study, laparoscopic rectal resection was performed first and then laparoscopic gastric resection and reconstruction were followed, which was different from some reports in which laparoscopic gastric resection and reconstruction were performed before laparoscopic rectal resection.[11] In theory, if laparoscopic gastric resection was performed first and in case of severe intraoperative bleeding, blood accumulating in the pelvic cavity might affect the observation and operation of the laparoscopic rectal resection. Our surgeons, who are specialized in laparoscopic surgery, have performed numerous laparoscopic surgeries including appendectomy, pancolectomy, radical resection for colon and rectal caner, and radical resection for gastric cancer. Thus, compared with other 10 reported cases of simultaneous laparoscopy-assisted resection for synchronous rectal and gastric cancers, patients in the present study were older but had less intraoperative blood loss, shorter operation time, and shorter postoperative hospital stays. In addition, the role of multidisciplinary physicians in a safe recovery of patients seems to be vital. The departments of cardiology, endocrinology, and neurology were consulted for blood pressure and blood glucose control to reduce the risk of malignant hypertension, cerebral infarction, and postoperative delirium. Blood pressure was in control, especially during anesthesia induction, to avoid cerebral accident. In addition, the surgical intensive care unit made great contributions to help early resuscitation and hold homeostasis to create conditions for early mobility. The advanced laparoscopic technology has become an attractive method in the treatment of digestive synchronous MPC, especially for elderly patients. If laparoscopic surgery is performed by experienced surgeons for synchronous rectal and gastric cancer simultaneously, it is safe and feasible, with the advantages of a better cosmetic result, faster recovery, and a lower incidence of complications, with no influence on the short-term prognosis of cancer. In addition, closed cooperation among multidisciplinary physicians plays a crucial role in the care of the patient perioperatively.
Table 1.

Preoperative Clinical Data of the 3 Patients

CaseSexAge (y)BMIAccompanied Medical IllnessesLocation of Gastric CancerLocation of Rectal Cancer
1Female7818.5Hypertension, type 2 diabetes, cerebral infarction, medium anemia, lung infectionCorpus ventriculiLower rectum
2Female7525.6Hypertension, cerebral infarction, hyperlipidemiaGastric antrumUpper rectum
3Female5522.1HyperlipidemiaGastric antrumUpper rectum

BMI, body mass index.

Table 2.

Perioperative and Postoperative Data of the 3 Patients

CaseSurgical MethodAssisted Incision (cm)Operation Time (min)Intraoperative Bleeding (mL)Time to Remove Drainage Tubes (days)Time to Resume Oral Intake (day)Postoperative Hospital Stay (day)Complication
1LALAR + LADG5260604413None
2LALAR + LADG5255804514None
3LALAR + LADG5245303310None

LALAR = laparoscopy-assisted low anterior resection; LADG = laparoscopy-assisted distal gastrectomy.

Table 3.

Oncologic Outcomes of the 3 Patients

CaseCancerPathologic TypeTumor InvadingMargin of SpecimenLymph NodeMetastasisTNM StagingPrognosis
1Gastric cancerModerately poor differentiated adenocarcinomaSerosa layerNegative0/16NoneT3N0M0, stage IIASurvivable (33 mo later)
Rectal cancerPoor differentiated adenocarcinomaMuscular layerNegative0/16NoneT2N0M0, stage I
2Gastric cancerModerately poor differentiated adenocarcinomaSerosa layerNegative2/20NoneT3N1M0, stage IIBSurvivable (32 mo later)
Rectal cancerModerately differentiated adenocarcinomaMuscular layerNegative0/16NoneT2N0M0, stage I
3Gastric cancerModerately poor differentiated adenocarcinomaSubmucosa layerNegative0/25NoneT1bN0M0, stage IASurvivable (1 mo later)
Rectal cancerModerately differentiated adenocarcinomaSerosa layerNegative1/24NoneT4aN1M0, stage IIIB
  14 in total

1.  Comparison of laparoscopy-assisted and total laparoscopic Billroth-I gastrectomy for gastric cancer: a report of short-term outcomes.

Authors:  Takahiro Kinoshita; Hidehito Shibasaki; Takashi Oshiro; Mitsuru Ooshiro; Shinichi Okazumi; Ryoji Katoh
Journal:  Surg Endosc       Date:  2010-10-23       Impact factor: 4.584

2.  Laparoscopic surgery for synchronous gastric and colorectal cancer: a preliminary experience.

Authors:  Masanori Tokunaga; Naoki Hiki; Tetsu Fukunaga; Hiroya Kuroyanagi; Akira Miki; Takashi Akiyoshi; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2009-06-04       Impact factor: 3.445

3.  Gastric cancer patients at high-risk of having synchronous cancer.

Authors:  Jun Ho Lee; Ja Seong Bae; Keun Won Ryu; Jong Seok Lee; Sook Ryun Park; Chan Gyoo Kim; Myoung Cheorl Kook; Il Ju Choi; Young Woo Kim; Jae-Gahb Park; Jae-Moon Bae
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  Short-term outcomes after laparoscopic-assisted proctectomy for rectal cancer: results from the ACS NSQIP.

Authors:  David Yu Greenblatt; Victoria Rajamanickam; Andrew J Pugely; Charles P Heise; Eugene F Foley; Gregory D Kennedy
Journal:  J Am Coll Surg       Date:  2011-03-16       Impact factor: 6.113

5.  A case-control study of laparoscopy-assisted and open distal gastrectomy for advanced gastric cancer.

Authors:  Jianbo Shuang; Shengbin Qi; Jianyong Zheng; Qinchuan Zhao; Jipeng Li; Zhenghua Kang; Jin Hua; Jianjun Du
Journal:  J Gastrointest Surg       Date:  2010-10-22       Impact factor: 3.452

6.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.

Authors:  Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer
Journal:  Lancet Oncol       Date:  2008-12-13       Impact factor: 41.316

7.  Laparoscopy-assisted combined resection for synchronous gastric and colorectal cancer: report of three cases.

Authors:  Hideo Matsui; Yuichi Okamoto; Akiko Ishii; Kazuhiro Ishizu; Yasumasa Kondoh; Naoki Igarashi; Kyoji Ogoshi; Hiroyasu Makuuchi
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

8.  Simultaneous laparoscopy-assisted low anterior resection and distal gastrectomy for synchronous carcinoma of rectum and stomach.

Authors:  Qian-Lin Zhu; Min-Hua Zheng; Bo Feng; Ai-Guo Lu; Min-Liang Wang; Jian-Wen Li; Wei-Guo Hu; Lu Zang; Zhi-Hai Mao; Feng Dong; Jun-Jun Ma; Ya-Ping Zong
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case.

Authors:  Roberto Dell'Avanzato; Fabio Carboni; Maria Beatrice Palmieri; Raffaele Palmirotta; Fiorella Guadagni; Giovanna Pippa; Giuseppe Santeusanio; Mauro Antimi; Massimo Lopez; Massimo Carlini
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

10.  Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer.

Authors:  Shin Saito; Yoshinori Hosoya; Kazutomo Togashi; Kentaro Kurashina; Hidenori Haruta; Masanobu Hyodo; Koji Koinuma; Hisanaga Horie; Yoshikazu Yasuda; Hideo Nagai
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

View more
  2 in total

1.  A 66-Year-Old Man Presenting with Port-Site Metastatic Gastric Adenocarcinoma 4 Years After Laparoscopic Resection of a Rectal Adenocarcinoma.

Authors:  Riyadh Hakami; Elham Alzahrani; Ahmed Binjaloud; Sulaiman Alshammari; Turki Alshammari; Amany A Fathaddin; Mohammed Ayesh Zayed; Maha-Hamadien Abdulla; Omar Al-Obeed
Journal:  Am J Case Rep       Date:  2022-05-04

2.  Simultaneous robotic subtotal gastrectomy and right hemicolectomy for synchronous adenocarcinoma of stomach and colon.

Authors:  Byoung Jo Suh; Sung Jin Oh; Jin Yong Shin; Do Hoon Ku; Dong Sik Bae; Jong Kwon Park
Journal:  J Robot Surg       Date:  2017-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.